Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-06

LBRX vs MLYS: stock comparison and AI forecast

Lb Pharmaceuticals Inc (LBRX) and Mineralys Therapeutics, Inc. (MLYS) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

LBRX Lb Pharmaceuticals Inc

Price
$42.01 +31.4% · 6M
Market Cap
$1.36B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

MLYS Mineralys Therapeutics, Inc.

Market Cap
$1.36B
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

LBRX · MLYS

Key facts

  • LBRX and MLYS have similar market capitalizations ($1.36B and $1.36B).
  • MLYS carries 0.25 times debt per unit of equity, against 0.09 times for LBRX.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricLBRXMLYS
Market Cap$1.36B$1.36B
P/B Ratio3.24x2.69x
EPS$-6.73$-4.60
Book Value/Share$12.95$5.70
FCF/Share$-4.46–

Profitability & Margins

MetricLBRXMLYS
ROE-36.2%-73.4%
ROA-33.4%-58.7%
ROIC–-67.5%
Tax Rate0.0%–

Financial Health

MetricLBRXMLYS
Current Ratio14.78x11.83x
D/E Ratio0.09x0.25x
Financial Leverage1.09x1.25x
Working Capital$417M$575M

Cash Flow

MetricLBRXMLYS
Operating Cash Flow-$143M-$153M
Free Cash Flow-$144M–
Capital Spending-$510K–

Income Statement

MetricLBRXMLYS
Operating Income–-$390M
Net Income-$151M-$370M
R&D Expense$125M$293M

Dividend & Shareholder Information

MetricLBRXMLYS
Shares Outstanding32M88M
FAQ

LBRX vs MLYS: stock comparison and AI forecast

Which is bigger, LBRX or MLYS?

LBRX and MLYS have similar market capitalizations ($1.36B and $1.36B).

Which one does Intratio's AI model rank higher, LBRX or MLYS?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.